4D Molecular Therapeutics, Inc. (FDMT) shares outstanding

Shares outstanding · fiscal 2025
57.93M

4D Molecular Therapeutics, Inc. (FDMT) had 57.93M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 7.4% higher than the 53.94M of fiscal 2024. Figures as of 18 Nov 2026, 11:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
57.93M
Change on fiscal 2024
+7.4%
Highest on record
57.93Mfiscal 2025
Lowest on record
27.73Mfiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

4D Molecular Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 56.38M shares outstanding today.

Across the 5 fiscal years on record (2021–2025), the highest was 57.93M in fiscal 2025 and the lowest 27.73M in fiscal 2021.

History · 5 fiscal years

Shares outstanding by fiscal year

4D Molecular Therapeutics, Inc. shares outstanding, year by year

4D Molecular Therapeutics, Inc. (FDMT) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202557.93M 7.4% up
202453.94M 37.9% up
202339.13M 21.0% up
202232.35M 16.7% up
202127.73M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on FDMT

4D Molecular Therapeutics, Inc., figure by figure

4D Molecular Therapeutics, Inc. (FDMT) overview: price, valuation and scorecard

4D Molecular Therapeutics, Inc. shares outstanding: questions and answers

How many shares does 4D Molecular Therapeutics, Inc. have?

4D Molecular Therapeutics, Inc. (FDMT) had 57.93M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 7.4% higher than the 53.94M of fiscal 2024. The market data feed counts 56.38M shares outstanding today.

What are the highest and lowest diluted share count figures on record for 4D Molecular Therapeutics, Inc.?

Across the 5 fiscal years on record (2021–2025), the highest was 57.93M in fiscal 2025 and the lowest 27.73M in fiscal 2021.

How is 4D Molecular Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For 4D Molecular Therapeutics, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “4D Molecular Therapeutics, Inc. (FDMT) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/FDMT/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.